ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

DYN Dyne Therapeutics Inc

26.00
0.05 (0.19%)
May 10 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Dyne Therapeutics Inc DYN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 0.19% 26.00 18:59:59
Open Price Low Price High Price Close Price Previous Close
25.96 25.07 26.48 26.00 25.95
more quote information »

Recent News

Date Time Source Heading
5/02/202415:10GLOBEDyne Therapeutics Reports First Quarter 2024 Financial..
3/27/202415:05GLOBEDyne Therapeutics Reports Inducement Grant Under Nasdaq..
3/27/202407:30GLOBEDyne Therapeutics to Present at the Cantor Virtual Muscular..
3/25/202406:30GLOBEDyne Therapeutics Announces CEO Transition
3/13/202406:30GLOBEDyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
3/11/202416:36EDGAR2Form 144 - Report of proposed sale of securities
3/11/202416:35EDGAR2Form 144 - Report of proposed sale of securities
3/11/202416:35EDGAR2Form 144 - Report of proposed sale of securities
3/08/202415:53EDGAR2Form 144 - Report of proposed sale of securities
3/07/202419:19EDGAR2Form 144 - Report of proposed sale of securities
3/07/202419:18EDGAR2Form 144 - Report of proposed sale of securities
3/07/202419:16EDGAR2Form 144 - Report of proposed sale of securities
3/05/202407:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
3/05/202406:41EDGAR2Form 8-K - Current report
3/05/202406:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/05/202406:35EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/05/202406:30GLOBEDyne Therapeutics Reports Fourth Quarter and Full Year 2023..
3/01/202420:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202420:33EDGAR2Form 144 - Report of proposed sale of securities
3/01/202416:08EDGAR2Form 144 - Report of proposed sale of securities
2/29/202418:49EDGAR2Form 144 - Report of proposed sale of securities
2/23/202416:23EDGAR2Form 144 - Report of proposed sale of securities
2/14/202415:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:15GLOBEDyne Therapeutics Announces Upcoming Presentations on..
2/14/202407:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202416:40EDGAR2Form 144 - Report of proposed sale of securities
2/01/202406:30GLOBEDyne Therapeutics to Present at February Investor..
1/26/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/26/202418:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/26/202418:46EDGAR2Form 144 - Report of proposed sale of securities
1/11/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/11/202415:05GLOBEDyne Therapeutics Announces Closing of Public Offering of..
1/05/202415:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/05/202407:02EDGAR2Form 8-K - Current report
1/05/202406:30GLOBEDyne Therapeutics to Present at 42nd Annual J.P. Morgan..
1/04/202421:46GLOBEDyne Therapeutics Announces Pricing of $300 Million Public..
1/04/202420:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202420:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202420:45EDGAR2Form 144 - Report of proposed sale of securities
1/04/202420:45EDGAR2Form 144 - Report of proposed sale of securities
1/04/202420:19EDGAR2Form S-3MEF - Registration adding securities to prior Form..
1/04/202416:12EDGAR2Form 8-K - Current report
1/03/202419:14EDGAR2Form 144 - Report of proposed sale of securities
1/03/202419:12EDGAR2Form 144 - Report of proposed sale of securities
1/03/202415:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/03/202415:25GLOBEDyne Therapeutics Announces Proposed Public Offering of..
1/03/202405:37EDGAR2Form 8-K - Current report
1/03/202405:30GLOBEDyne Therapeutics Announces Positive Initial Clinical Data..
1/02/202415:05GLOBEDyne Therapeutics to Host Virtual Event Tomorrow, January 3..
12/29/202320:03EDGAR2Form 144 - Report of proposed sale of securities

Your Recent History

Delayed Upgrade Clock